Vertex Pharmaceuticals (VRTX)

Depreciation & Amortization

$222.10M

TTM · Period ending: · USD

VRTX logo

VRTX Depreciation & Amortization

Latest reported$222.10M
VRTX TTM Depreciation & Amortization ($2.80M → $222.10M)
High-resolution chart · PNG

VRTX depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
222,100,000
217,300,000
209,800,000
200,600,000
199,800,000
202,100,000
207,200,000
219,700,000
208,600,000
196,000,000
181,300,000
160,700,000
155,300,000
151,200,000
148,300,000
143,732,000
138,728,000
132,728,000
125,662,000
121,185,000
116,131,000
111,528,000
109,515,000
106,416,000
105,621,000
106,622,000
106,941,000
99,511,000
92,856,000
83,217,000
72,420,000
70,026,000
66,059,000
62,890,000
61,397,000
60,416,000
59,760,000
59,833,000
61,398,000
61,694,000
63,293,000
62,395,000
62,343,000
62,932,000
63,725,000
63,832,000
63,257,000
64,552,000
57,080,000
53,462,000
48,365,000
43,107,000
42,211,000
40,322,000
38,191,000
35,542,000
34,699,000
34,743,000
35,041,000
33,522,000
32,530,000
31,733,000
30,459,000
30,637,000
30,694,000
30,527,000
30,107,000
30,299,000
31,437,000
31,862,000
32,196,000
31,072,000
29,954,000
28,636,000
27,459,000
26,883,000
25,982,000
25,939,000
25,868,000
25,882,000
26,977,000
26,699,000
27,289,000
28,423,000
28,602,000
29,355,000
29,640,000
27,438,000
23,136,000
23,314,000
23,438,000
24,914,000
28,580,000
27,399,000
25,432,000
23,859,000
23,945,000
20,723,000
17,964,000
14,936,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.